Published 6 July 2004. doi:10.1084/jem.20040566
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 200, Number 1, 69-78
15-epi-lipoxin A4mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute Inflammation
Mark J. Paul-Clark1,
Thong van Cao1,
Niloufar Moradi-Bidhendi2,
Dianne Cooper1, and
Derek W. Gilroy1
1 Department of Biochemical Pharmacology and 2 Department of Clinical Pharmacology, William Harvey Research Institute, St. Bartholomew's Hospital and The Royal London School of Medicine and Dentistry, London EC1M 6BQ, England, UK
Address correspondence to Derek W. Gilroy, Dept. of Biochemical Pharmacology, William Harvey Research Institute, St. Bartholomew's Hospital and The Royal London School of Medicine and Dentistry, Charterhouse Sq., London EC1M 6BQ, England, UK. Phone: 44-207-882-6069; Fax: 44-207-882-6076; email: d.w.gilroy{at}qmul.ac.uk
The established model for the mechanism of action of aspirin is the inhibition of prostaglandin synthesis. However, this has never fully explained aspirin's repertoire of antiinflammatory properties. We found in acute pleuritis that aspirin, but not salicylate, indomethacin, or piroxicam, increased plasma nitric oxide (NO), which correlated with a reduction in inflammation. Inhibiting aspirin-elicited NO pharmacologically in this model nullified the antiinflammatory effects of aspirin. Moreover, aspirin was not antiinflammatory in either constitutive (eNOS) or inducible NO synthase (iNOS) knockout mice with IL-1ßinduced peritonitis. It transpires that aspirin generates NO through its unique ability to trigger the synthesis of 15-epi-lipoxin A4. Aspirin and 15-epi-lipoxin A4 were shown to inhibit leukocyte trafficking in an NO-dependent manner using intravital microscopy on IL-1ßstimulated mouse mesentery. Not only did aspirin inhibit leukocyteendothelial interaction in a manner similar to NO in wild-type mice but both aspirin and 15-epi-lipoxin A4 had markedly reduced effects on leukocyteendothelial cell adherence in eNOS- and iNOS-deficient mice compared with wild type. Collectively, these data suggest that aspirin triggers the synthesis of 15-epi-lipoxin A4, which increases NO synthesis through eNOS and iNOS. This aspirin-elicited NO exerts antiinflammatory effects in the microcirculation by inhibiting leukocyteendothelium interactions.
Key Words: leukocyte trafficking resolution nonsteroidal antiinflammatory drugs epi-lipoxins microvascular endothelium
Abbreviations used in this paper: ANOVA, analysis of variance; COX, cyclooxygenase; eNOS, constitutive NO synthase; iNOS, inducible NO synthase; L-NAME, NG-nitro-L-arginine methyl ester; nNOS, neuronal NO synthase; NO, nitric oxide; NSAID, nonsteroidal antiinflammatory drug.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Machado, F. S., Esper, L., Dias, A., Madan, R., Gu, Y., Hildeman, D., Serhan, C. N., Karp, C. L., Aliberti, J.
(2008). Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6. J. Exp. Med.
205: 1077-1086
[Abstract]
[Full Text]
-
Tailor, A., Wood, K. C., Wallace, J. L., Specian, R. D., Granger, D. N.
(2007). Roles of platelet and endothelial cell COX-1 in hypercholesterolemia-induced microvascular dysfunction. Am. J. Physiol. Heart Circ. Physiol.
293: H3636-H3642
[Abstract]
[Full Text]
-
Haworth, O., Levy, B. D.
(2007). Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J
30: 980-992
[Abstract]
[Full Text]
-
Negrotto, S., Malaver, E., Alvarez, M. E., Pacienza, N., D'Atri, L. P., Pozner, R. G., Gomez, R. M., Schattner, M.
(2006). Aspirin and Salicylate Suppress Polymorphonuclear Apoptosis Delay Mediated by Proinflammatory Stimuli. J. Pharmacol. Exp. Ther.
319: 972-979
[Abstract]
[Full Text]
-
Chiang, N., Serhan, C. N., Dahlen, S.-E., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., Brink, C.
(2006). The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo. Pharmacol. Rev.
58: 463-487
[Abstract]
[Full Text]
-
Levy, B. D.
(2006). Myocardial 15-Epi-lipoxin A4 Generation Provides a New Mechanism for the Immunomodulatory Effects of Statins and Thiazolidinediones. Circulation
114: 873-875
[Full Text]
-
Birnbaum, Y., Ye, Y., Lin, Y., Freeberg, S. Y., Nishi, S. P., Martinez, J. D., Huang, M.-H., Uretsky, B. F., Perez-Polo, J. R.
(2006). Augmentation of Myocardial Production of 15-Epi-Lipoxin-A4 by Pioglitazone and Atorvastatin in the Rat. Circulation
114: 929-935
[Abstract]
[Full Text]
-
Rajakariar, R., Yaqoob, M. M., Gilroy, D. W.
(2006). COX-2 in Inflammation and Resolution. Mol. Interv.
6: 199-207
[Abstract]
[Full Text]
-
Hudert, C. A., Weylandt, K. H., Lu, Y., Wang, J., Hong, S., Dignass, A., Serhan, C. N., Kang, J. X.
(2006). Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc. Natl. Acad. Sci. USA
103: 11276-11281
[Abstract]
[Full Text]
-
Levy, B. D., Bonnans, C., Silverman, E. S., Palmer, L. J., Marigowda, G., Israel, E., for the Severe Asthma Research Program, National H,
(2005). Diminished Lipoxin Biosynthesis in Severe Asthma. Am. J. Respir. Crit. Care Med.
172: 824-830
[Abstract]
[Full Text]
-
Schroder, H.
(2005). New signaling routes for an old drug: lipoxin A4 might mediate heme oxygenase-1 induction by aspirin. Focus on "Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells". Am. J. Physiol. Cell Physiol.
289: C507-C508
[Full Text]
-
Flower, R. J., Perretti, M.
(2005). Controlling inflammation: a fat chance?. J. Exp. Med.
201: 671-674
[Abstract]
[Full Text]
-
Fiorucci, S., Di Lorenzo, A., Renga, B., Farneti, S., Morelli, A., Cirino, G.
(2004). Nitric Oxide (NO)-Releasing Naproxen (HCT-3012 [(S)-6-Methoxy-{alpha}-methyl-2-naphthaleneacetic Acid 4-(Nitrooxy)butyl Ester]) Interactions with Aspirin in Gastric Mucosa of Arthritic Rats Reveal a Role for Aspirin-Triggered Lipoxin, Prostaglandins, and NO in Gastric Protection. J. Pharmacol. Exp. Ther.
311: 1264-1271
[Abstract]
[Full Text]